Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.2%

1 terminated out of 31 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

23%

7 trials in Phase 3/4

Results Transparency

31%

5 of 16 completed with results

Key Signals

5 with results94% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (19)
Early P 1 (1)
P 1 (1)
P 2 (2)
P 3 (3)
P 4 (4)

Trial Status

Completed16
Unknown5
Not Yet Recruiting3
Recruiting3
Withdrawn2
Active Not Recruiting1

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT07737782Not Yet Recruiting

Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause.

NCT07701863Not ApplicableNot Yet Recruiting

F-GYN for Vaginal Dryness and Vulvovaginal Atrophy

NCT07574216Not ApplicableNot Yet Recruiting

VEDA Study (DHEA vs Estradiol)

NCT07386249Not ApplicableRecruitingPrimary

Exploration of the Effect of a Wheat Polar Lipid Complex on Vaginal Dryness in Healthy Postmenopausal Women

NCT06962345Not ApplicableRecruiting

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

NCT06900374Not ApplicableRecruitingPrimary

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

NCT07420647Not ApplicableActive Not Recruiting

Pilot Study of Individualized Treatment for Genitourinary Syndrome of Menopause in Women After Cancer Treatment

NCT05913479Not ApplicableCompletedPrimary

Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer

NCT06964646Phase 4CompletedPrimary

Assess Efficacy, Safety, and Tolerability of 8 Weeks of Vaginal Hyaluronic (V-HYAL) Gel in Peri- and Post-Menopausal Female

NCT06282614Not ApplicableTerminatedPrimary

Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

NCT05644444Not ApplicableCompleted

Effectiveness and Safety of a Water-based and a Silicone-based Personal Lubricants With Sensory Action

NCT03307044Not ApplicableCompleted

Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

NCT03666819Phase 2Withdrawn

Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy

NCT03372720Not ApplicableCompleted

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

NCT05156502Not ApplicableUnknown

To Assess Signs and Symptoms in Women Affected by GSM After One Cycle of Pixel CO2-Alma Fractionated Laser

NCT04908124Phase 3Completed

A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants.

NCT03178825Not ApplicableCompleted

Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause

NCT02176083Not ApplicableCompleted

Reproductive Health Survivorship Care Plan Pilot

NCT04342559Not ApplicableCompletedPrimary

Acceptability, Under Use in Real Conditions Of Two Vaginal Moistures Indicated for Women With Vaginal Drying

NCT03714581Not ApplicableUnknown

Laser Therapy Following Radiotherapy for Gynecological Cancer

Scroll to load more

Research Network

Activity Timeline